Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Kirtschig, G; Becker, K; Günthert, A; Jasaitiene, D; Cooper, S; Chi, CC; Kreuter, A; Rall, KK; Aberer, W; Riechardt, S; Casabona, F; Powell, J; Brackenbury, F; Erdmann, R; Lazzeri, M; Barbagli, G; Wojnarowska, F.
Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.
J Eur Acad Dermatol Venereol. 2015; 29(10):e1-43 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Aberer Werner

Dimensions Citations:

Plum Analytics:
Lichen sclerosus (LS) is an inflammatory skin disease that usually involves the anogenital area. All patients with symptoms or signs suspicious of lichen sclerosus should be seen at least once initially by a physician with a special interest in the disease in order to avoid delay in diagnosis, as early treatment may cure the disease in some and reduce or prevent scarring. The diagnosis is made clinically in most cases. Biopsies should only be performed under certain circumstances. The gold standard for treatment remains potent to very potent topical steroids; however, mild and moderate disease in boys and men may be cured by circumcision. Certain triggers should be avoided. © 2015 European Academy of Dermatology and Venereology.
Find related publications in this database (using NLM MeSH Indexing)
Anus Diseases - drug therapy
Anus Diseases - pathology
Anus Diseases - surgery
Biopsy -
Circumcision, Male -
Evidence-Based Medicine -
Female -
Humans -
Laser Therapy -
Lichen Sclerosus et Atrophicus - drug therapy
Lichen Sclerosus et Atrophicus - pathology
Lichen Sclerosus et Atrophicus - surgery
Male -
Penile Diseases - drug therapy
Penile Diseases - pathology
Penile Diseases - surgery
Photochemotherapy -
Vulvar Lichen Sclerosus - drug therapy
Vulvar Lichen Sclerosus - pathology
Vulvar Lichen Sclerosus - surgery

© Meduni Graz Impressum